Human Myoblast Genome Therapy (HMGT) is a platform technology of cell transplantation, nuclear transfer, and tissue engineering. Unlike stem cells, myoblasts are differentiated, immature cells destined to become muscl...
Objectives This study investigated the efficacy of human skeletal myoblasts (SkM) mediated either human vascular endothelial growth factor-165 (hVEGF165) or angiopoietin-1 (Ang-1) on vascular development and myocardia...
Myocardial regeneration is an exciting new frontier for the treatment of heart disease. Many approaches are currently being tested. The use of autologous skeletal myoblasts has been the earliest, with over 10 years of...